- Japan: The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. As a result of these measures, domestic sales increased, while capital expenditure in hospitals was cautious. Sales in the clinic, private hospital, and public hospital markets increased. Sales in the university market remained flat.
- International: Sales in North America, Europe, and Asia & Other increased favorably. Overseas sales achieved double-digit growth on a comparable basis excluding the currency effect and the impact of the consolidation of Ad-Tech. Sales in North America showed double-digit growth, posting a significant increase in sales of neurology products including Ad-Tech as well as favorable sales of ventilators. Sales of Patient Monitors decreased compared to the strong growth in the same period of the previous fiscal year. Sales in Latin America decreased, mainly in Mexico and Colombia. Sales in Europe increased favorably, especially in Italy, Turkey, and Spain. In Asia & Other, sales in Thailand and Vietnam showed strong growth and sales in the Middle East & Africa also increased significantly due to large orders in Morocco.
（Years ended/ending March 31, million yen）
|
2025 2Q (6 months) |
2026 2Q (6 months) |
YoY (%) |
|
|
Domestic Sales |
66,243 |
66,880 |
1.0 |
|
Overseas Sales (Overseas Sales Ratio) |
36,541 (35.6%） |
41,240 （38.1%） |
12.9 |
|
North America |
19,281 |
22,317 |
15.7 |
|
Latin America |
2,225 |
2,007 |
-9.8 |
|
Europe |
5,741 |
6,204 |
8.1 |
|
Asia & Other |
9,292 |
10,711 |
15.3 |
